Over-the-counter antibiotics compromising aminoglycoside activity
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkae376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von A Robertson und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Nonprescription Drugs, Aminoglycosides, Microbial Sensitivity Tests. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cardiff University.
Abstract (Originalsprache)
Introduction
Antimicrobial resistance (AMR) is a global issue that needs addressing. While antibiotic stewardship has improved often by restricting antibiotic use, some antibiotics that are still sold legally over the counter (OTC), notably in sore throat medications. Recent findings suggest OTC antibiotics could trigger cross-resistance to antibiotics used in clinical treatments, whether systemic or topical. Here we investigated the impact of three antibiotics contained in OTC sore throat medicines on emerging AMR in vitro.
Methods
Bacterial pathogens were exposed to a bactericidal concentration of an aminoglycoside in the presence or absence of a during-use concentration of bacitracin, gramicidin or tyrothricin in a time–kill assay. Damage to the bacterial membrane was also investigated by measuring potassium leakage and membrane potential alteration post-OTC antibiotic exposure.
Results
Gramicidin (15 µg/mL) significantly decreased the bactericidal activity of amikacin, tobramycin or gentamicin in Acinetobacter baumannii. It also decreased gentamicin bactericidal activity in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae, while tyrothricin decreased the aminoglycoside efficacy in E. cloacae and E. coli. Gramicidin significantly decreased bacterial membrane potential and caused significant potassium leakage.
Conclusion
Gramicidin and to some extent tyrothricin impacted aminoglycoside efficacy by affecting membrane potential, which is essential for aminoglycosides uptake. Thus, some OTC antibiotics can interfere with aminoglycoside activity, which could in turn affect treatment efficacy. Although the likelihood of OTC antibiotics and aminoglycosides being used at the same time might not be common, this research highlights one potential reason for OTC antibiotics’ usage to result in treatment failure and their contribution to AMR development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.
- Medical Marketing, Reckitt Benckiser, Slough, UK.
- School of Medicine, Cardiff University, Cardiff, UK.
ORCID-Profile: A Robertson, E Mantzourani, J Y Maillard
Förderung
- Cardiff University
Zitieren
APA
Robertson, A., Coutinho, G., Mantzourani, E., Szomolay, B., Pillay, T., Shephard, A., & Maillard, J. Y. (2025). Over-the-counter antibiotics compromising aminoglycoside activity. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae376
Vancouver
Robertson A, Coutinho G, Mantzourani E, Szomolay B, Pillay T, Shephard A, et al. Over-the-counter antibiotics compromising aminoglycoside activity. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkae376
BibTeX
@article{Robertson2025,
author = {Robertson, A and Coutinho, G and Mantzourani, E and Szomolay, B and Pillay, T and Shephard, A and Maillard, J Y},
title = {Over-the-counter antibiotics compromising aminoglycoside activity},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkae376}
}
EUVIMED